Nasdaq

LENZ Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)CIK 0001815776Solana Beach, CaliforniaFilings at SEC EDGAR

At a glance

Most recent filing on November 2, 2026 — a sale by RA CAPITAL MANAGEMENT, L.P. on Oct 29, 2026.

We hold 3 Form 4 lines, going back to November 2, 2026.

Insider trades

All 3 shown

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

RA CAPITAL MANAGEMENT, L.P. 10% owner
$360,091Open-market sale
TradedOct 29, 2026FiledNov 2, 2026
RA CAPITAL MANAGEMENT, L.P. 10% owner
$1,518,713Open-market sale
TradedOct 29, 2026FiledNov 2, 2026
RA CAPITAL MANAGEMENT, L.P. 10% owner
$7,255,974Open-market sale
TradedOct 29, 2026FiledNov 2, 2026